reports
Press Release: Dupixent late-breaking positive pivotal data in bullous...
Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also seen in disease severity and itchDupixent also significantly reduced oral corticosteroid and rescue medicine use compared to placebo Data support the potential of Dupixent to be the first and only targeted medicine to treat bullous pemphigoid, a skin disease with underlyin...
Communiqué de presse : Présentation de dernière heure de données pivot...
Communiqué de presse : Présentation de dernière heure de données pivots positives sur le Dupixent dans le traitement de la pemphigoïde bulleuse à l’AAD Présentation de dernière heure de données pivots positives sur le Dupixent dans le traitement de la pemphigoïde bulleuse à l’AAD Cinq fois plus d’adultes traités par Dupixent présentaient une rémission soutenue à la semaine 36, comparativement à ceux traités par placebo ; des réductions significatives de la sévérité de la maladie et des démangeaisons ont également été observées. Le Dupixent a aussi significativement réduit les prises de cor...
Dupixent® (dupilumab) Late-Breaking Positive Pivotal Data in Bullous P...
Dupixent® (dupilumab) Late-Breaking Positive Pivotal Data in Bullous Pemphigoid Presented at AAD Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also seen in disease severity and itch Dupixent also significantly reduced oral corticosteroid and rescue medicine use compared to placebo Data support the potential of Dupixent to be the first and only targeted medicine to treat bullous pemphigoid, a skin disease with underlying type 2 inflammation; regulatory submissions are under review in the U.S. and the Eur...
Kaldalón hf.: Annual General Meeting 3 April 2025
Kaldalón hf.: Annual General Meeting 3 April 2025 The Board of Directors of Kaldalón hf. hereby announces that the Annual General Meeting of the company will be held on Wednesday, April 3, 2025, at 16:00 GMT. The meeting will be held at Reykjavík Natura, Nauthólsvegur 52, 101 Reykjavík. Enclosed is the agenda for the Annual General Meeting. Meeting documents and further information concerning the meeting is available on the website .
Kaldalón hf.: Aðalfundur 3. apríl 2025
Kaldalón hf.: Aðalfundur 3. apríl 2025 Stjórn Kaldalóns hf. boðar til aðalfundar í félaginu miðvikudaginn 3. apríl 2025 kl. 16:00. Fundurinn verður haldinn á á Reykjavík Natura, Nauthólsvegi 52, 101 Reykjavík. Meðfylgjandi er fundarboð aðalfundar og dagskrá. Gögn fundar má jafnframt finna á Viðhengi
Late-Breaking ESK-001 Phase 2 OLE Data Presented at 2025 AAD Annual Me...
Late-Breaking ESK-001 Phase 2 OLE Data Presented at 2025 AAD Annual Meeting Demonstrate Robust Clinical Responses Over 52-Weeks in Psoriasis ESK-001 is a highly selective, next-generation oral tyrosine kinase 2 (TYK2) inhibitor currently under development in moderate-to-severe plaque psoriasis and systemic lupusPhase 2 OLE data of ESK-001 at 40 mg BID demonstrated sustained or increasing clinical responses through week 52 on PASI 90, PASI 100, and sPGA 0ESK-001 was generally well-tolerated at one year, with no new safety findingsData further support ESK-001’s potential to offer a highly dif...
Pinterest Inc: 3 directors
Three Directors at Pinterest Inc sold/sold after exercising options 93,072 shares at between 33.983USD and 35.750USD. The significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the...
Bright Minds Biosciences Inc: 1 director
A director at Bright Minds Biosciences Inc sold 5,000 shares at 36.197USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
Genting Berhad: 2 directors
Two Directors at Genting Berhad bought/maiden bought 2,898,200 shares at between 3.143MYR and 3.145MYR. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's di...
T7 Global Berhad: 2 directors
Two Directors at T7 Global Berhad sold/bought 33,528,668 shares at 0.470MYR. The significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
Vietnam German Steel Pipe Jsc: 1 director
A director at Vietnam German Steel Pipe Jsc sold 1,729,000 shares at 0.000VND and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
Link Real Estate Investment Trust: 1 director
A director at Link Real Estate Investment Trust sold 1,000,000 shares at 36.462HKD and the significance rating of the trade was 90/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...
Central Global Berhad: 1 director
A director at Central Global Berhad bought 2,250,000 shares at 0.890MYR and the significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
Galaxy Entertainment Group: 1 director
A director at Galaxy Entertainment Group sold 500,000 shares at 31.659HKD and the significance rating of the trade was 82/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
Enzymatica AB: 2 directors
A director at Enzymatica AB bought 40,000 shares at 2.860SEK and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
Net Insight AB: 1 director
A director at Net Insight AB bought 52,000 shares at 4.560SEK and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Canal+ S.A: 1 director
A director at Canal+ S.A bought 100,000 shares at 176p and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...
Silver Ridge Holdings Bhd: 1 director
A director at Silver Ridge Holdings Bhd bought 2,966,700 shares at 0.487MYR and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
TT Vision Holdings Berhad: 1 director
A director at TT Vision Holdings Berhad maiden bought 265,000 shares at 0.378MYR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...
Fortis Inc: 4 directors
Four Directors at Fortis Inc bought/sold after exercising options 134,604 shares at between 62.910CAD and 63.935CAD. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.